PreludeDx

0 followers


PreludeDx delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.

Industries

Headquarters

Stage

Employees

Links

Org chart

Daniel Forche
President & CEO

Daniel Forche

Collapse
Troy Bremer
Chief Scientific Officer
Edwin C. Hendrick
Chief Commercial Officer
David J. Dabbs
Chief, Pathology
Cory Dunn
VP, Product Development
Andrew Sundberg
VP, Global Sales
Matthew Tate
VP, Business Development
David L. Peterson
VP, Revenue Cycle
Leona Hamrick
Senior Director, Global Medical Affairs
Jess Savala
Medical Director
Kristen Apgar
Director, HR & Corporate Administration
Jasmin Valverde
Director, Operations & Project Management
Karuna Mittal
Director, Research & Development